Found 0 matching trials
Optimizing CAB-LA as PrEP for Women Who Inject Drugs N/A The goal of this study is to elicit information crucial for designing strat...
Show More Location
Prevention Point Philadelphia
Learn More & Join Trial
Long-Acting Treatment in Adolescents (LATA) PHASE3 The LATA trial will find out if taking a long-acting injectable form of HIV...
Show More Learn More & Join Trial
A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects PHASE2 This study is a Phase IIb, randomized, multicentre, parallel group, open-la...
Show More Location
GSK Investigational Site
Learn More & Join Trial
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy PHASE1 This is a Phase I/II, multicenter, open-label, non-randomized study with fo...
Show More Location
Site 4601, University of California, UC San Diego CRS- Mother-Child-Adolescent HIV Program
Learn More & Join Trial
Effect of Rifabutin on the Pharmacokinetics of Oral Cabotegravir in Healthy Subjects PHASE1 This is a Phase I, single-center, open-label, fixed-sequence, 2-period cros...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Safety, Tolerability and Acceptability of Long-Acting Cabotegravir (CAB LA) for the Prevention of HIV Among Adolescent Females PHASE2 This study will establish the minimum safety, tolerability and acceptabilit...
Show More Learn More & Join Trial
HIV Outpatient Monitoring Evaluation Through Self-collection of Dried Blood Spots N/A The goal of this observational study is to establish an operational framewo...
Show More Location
University of Colorado Hospital (UCHealth)
Learn More & Join Trial
A Study to Investigate if Long Acting Cabotegravir (CAB) and Lenacapavir (LEN) Injections Are Tolerable and Acceptable When Administered to Healthy Adults Without HIV PHASE1 This study will evaluate the tolerability and acceptability of injection si...
Show More Status
Active Not Recruiting
Location
GSK Investigational Site
Learn More & Join Trial
GSK1265744 (Cabotegravir, CAB) for Named Patient/Compassionate Use in HIV N/A The goal of this compassionate use program is to provide a mechanism to sup...
Show More Location
Multiple Locations
Learn More & Join Trial
Long-Acting Cabotegravir Plus VRC-HIVMAB075-00-AB (VRC07-523LS) for Viral Suppression in Adults Living With HIV-1 PHASE2 The purpose of this study was to assess the safety, tolerability, antiviral...
Show More Learn More & Join Trial